Karolinska Development's KDventures adopted articles of association in January 2026
Swedish life science investment company KDventures, part of Karolinska Development, adopted its current articles of association at an extraordinary general meeting on January 8, 2026. The company's business scope includes administrative services and consulting in medical development.
KDventures, the investment company within Karolinska Development, adopted its current articles of association at an extraordinary general meeting on January 8, 2026. The company's stated business object includes providing administrative services in financial, legal, corporate management, and personnel administration.
Furthermore, KDventures offers consultancy in medical development and clinical trials. The company is also authorized to own and manage shares and participations within the fields of medicine, biotechnology, pharmaceuticals, and medical technology.
The articles of association also permit the company to engage in activities compatible with these core areas. KDventures focuses on investments in the life science sector and provides regular updates on its portfolio companies' progress.
The full articles of association are available as a PDF, and the company invites interested parties to subscribe to its investor news for updates on portfolio developments and new deals.